Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 174
Titolo Tipologia Data di pubblicazione Autori File
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 01 - Articolo su rivista 2024 Villa, MatteoMalighetti, FedericaSharma, Geeta G.Manfroni, ChiaraFontana, DilettaCordani, NicolettaMeneveri, RaffaellaPiazza, RoccoPagni, FabioCortinovis, DiegoMologni, Luca +
A cross-sectional analysis of treatment patterns in small-cell lung cancer in five European countries 01 - Articolo su rivista 2024 Cortinovis, D +
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 01 - Articolo su rivista 2024 Seminati, DavideL'Imperio, VincenzoCasati, GabrielePilla, DanielaCortinovis, Diego LuigiBono, FrancescaPagni, Fabio +
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma 01 - Articolo su rivista 2024 Cortinovis, Diego +
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 01 - Articolo su rivista 2024 Cortinovis, DiegoPagni, Fabio +
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program 01 - Articolo su rivista 2024 Cortinovis, Diego +
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 01 - Articolo su rivista 2024 Cortinovis, Diego Luigi +
First-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study 01 - Articolo su rivista 2023 Cortinovis, D +
Novel Therapeutic Options for Small Cell Lung Cancer 01 - Articolo su rivista 2023 Abbate, MIBianchi, SPCortinovis, DL +
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer 01 - Articolo su rivista 2023 Diego Cortinovis +
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 01 - Articolo su rivista 2023 Cordani N.Bianchi T.Cortinovis D. L.Cazzaniga M. E.Lissoni A. A.Landoni F. +
Sharing Experience with Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors in Lung Cancer: An Italian Expert Panel Discussion 01 - Articolo su rivista 2023 Cortinovis, DL +
Project R. Evolution for improving clinical research in Italy: challenges and strategies 01 - Articolo su rivista 2022 Cortinovis, DiegoLuppi, Fabrizio +
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 01 - Articolo su rivista 2022 Cortinovis D.Seminati D.Pagni F. +
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 01 - Articolo su rivista 2022 Monaco, LaviniaDe Bernardi, ElisabettaCortinovis, DiegoCrivellaro, CinziaL'Imperio, VincenzoLandoni, ClaudioMathoux, GregoryPagni, FabioTurolla, Elia AnnaMessa, CristinaGuerra, Luca +
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature 01 - Articolo su rivista 2022 Carbone M.Abbate M. I.Invernizzi P.Bidoli P.Cortinovis D. +
Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial 01 - Articolo su rivista 2022 Cortinovis D +
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study 01 - Articolo su rivista 2022 Cortinovis D +
First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers 01 - Articolo su rivista 2022 Cortinovis D +
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer 01 - Articolo su rivista 2022 Cortinovis D +
Mostrati risultati da 1 a 20 di 174
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile